ALSERES PHARMACEUTICALS INC /DE Debt Conversion, Converted Instrument, Amount
ALSERES PHARMACEUTICALS INC /DE reported Debt Conversion, Converted Instrument, Amount of $13.00 million for the 254-month period ending 2013-12-31, per its 10-K filed 2014-04-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2014-04-10
- ALSERES PHARMACEUTICALS INC /DE debt conversion, converted instrument, amount for fiscal 2012 was $5.83M, a 18.75% decline from fiscal 2011.
- ALSERES PHARMACEUTICALS INC /DE debt conversion, converted instrument, amount for fiscal 2011 was $7.17M.
| Period end | Debt Conversion, Converted Instrument, Amount 12 month | Debt Conversion, Converted Instrument, Amount 242 month | Debt Conversion, Converted Instrument, Amount 245 month | Debt Conversion, Converted Instrument, Amount 248 month | Debt Conversion, Converted Instrument, Amount 251 month | Debt Conversion, Converted Instrument, Amount 254 month |
|---|---|---|---|---|---|---|
| 2013-12-31 | $13.00M 10-K · filed 2014-04-10 | |||||
| 2013-09-30 | $13.00M 10-Q · filed 2013-11-14 | |||||
| 2013-06-30 | $13.00M 10-Q · filed 2013-08-09 | |||||
| 2013-03-31 | $13.00M 10-Q · filed 2013-05-17 | |||||
| 2012-12-31 | $5.83M 10-K · filed 2014-04-10 | $13.00M 10-K · filed 2013-04-01 | ||||
| 2011-12-31 | $7.17M 10-K · filed 2013-04-01 |